Age

Visit number vs Lipid Lowering Medication: Number taken verified by inspection
N Mean StdDev Median Min Max Unknown Total
Baseline 318 1.1 ± 0.6 1.0 0.0 4.0 - 318
Follow-up 300 1.1 ± 0.6 1.0 0.0 4.0 1 301
Treatment Arm vs Lipid Lowering Medication: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 1.1 ± 0.6 1.0 0.0 4.0 - 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 106 1.1 ± 0.6 1.0 0.0 3.0 - 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 106 1.2 ± 0.6 1.0 0.0 3.0 - 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 106 1.2 ± 0.6 1.0 0.0 4.0 - 106
Treatment Arm vs Lipid Lowering Medication: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 1.1 ± 0.6 1.0 0.0 4.0 1 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 100 1.1 ± 0.6 1.0 0.0 3.0 - 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 101 1.2 ± 0.7 1.0 0.0 3.0 - 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 99 1.1 ± 0.6 1.0 0.0 4.0 1 100
Age category vs Lipid Lowering Medication: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 1.1 ± 0.6 1.0 0.0 4.0 - 318
45-54 years 53 1.1 ± 0.7 1.0 0.0 3.0 - 53
55-64 years 139 1.1 ± 0.7 1.0 0.0 4.0 - 139
65 years or older 126 1.3 ± 0.5 1.0 0.0 3.0 - 126
Age category vs Lipid Lowering Medication: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 1.1 ± 0.6 1.0 0.0 4.0 - 300
45-54 years 49 1.0 ± 0.6 1.0 0.0 3.0 - 49
55-64 years 127 1.1 ± 0.7 1.0 0.0 4.0 - 127
65 years or older 124 1.2 ± 0.6 1.0 0.0 3.0 - 124
Gender of the participant vs Lipid Lowering Medication: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 1.1 ± 0.6 1.0 0.0 4.0 - 318
Female 84 1.0 ± 0.5 1.0 0.0 3.0 - 84
Male 234 1.2 ± 0.6 1.0 0.0 4.0 - 234
Gender of the participant vs Lipid Lowering Medication: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 1.1 ± 0.6 1.0 0.0 4.0 1 301
Female 79 0.9 ± 0.5 1.0 0.0 2.0 - 79
Male 221 1.2 ± 0.6 1.0 0.0 4.0 1 222
Race of the participant vs Lipid Lowering Medication: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 1.1 ± 0.6 1.0 0.0 4.0 - 317
White 256 1.2 ± 0.6 1.0 0.0 4.0 - 256
American Indian or Alaskan Native 2 1.0 ± 0.0 1.0 1.0 1.0 - 2
Black or African American 43 0.8 ± 0.4 1.0 0.0 2.0 - 43
Asian 6 0.5 ± 0.5 0.5 0.0 1.0 - 6
Native Hawaiian or other Pacific islander 1 1.0 - 1.0 1.0 1.0 - 1
Other 4 0.8 ± 0.5 1.0 0.0 1.0 - 4
Multiple 5 0.6 ± 0.5 1.0 0.0 1.0 - 5
Race of the participant vs Lipid Lowering Medication: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 299 1.1 ± 0.6 1.0 0.0 4.0 - 299
White 241 1.2 ± 0.6 1.0 0.0 4.0 - 241
American Indian or Alaskan Native 2 1.0 ± 0.0 1.0 1.0 1.0 - 2
Black or African American 41 0.9 ± 0.5 1.0 0.0 2.0 - 41
Asian 6 0.5 ± 0.5 0.5 0.0 1.0 - 6
Native Hawaiian or other Pacific islander 1 1.0 - 1.0 1.0 1.0 - 1
Other 3 0.3 ± 0.6 0.0 0.0 1.0 - 3
Multiple 5 0.6 ± 0.5 1.0 0.0 1.0 - 5